首站-论文投稿智能助手
典型文献
Electromagnetic field exposure as a plausible approach to enhance the proliferation and differentiation of mesenchymal stem cells in clinically relevant scenarios
文献摘要:
Mesenchymal stem/stromal cell (MSC)-based therapy has been regarded as one of the most revolutionary breakthroughs in the history of modern medicine owing to its myriad of immunoregulatory and regenerative properties. With the rapid progress in the fields of osteo-and musculoskeletal therapies, the demand for MSC-based treatment modalities is becoming increasingly prominent. In this endeavor, researchers around the world have devised new and innovative techniques to support the proliferation of MSCs while minimizing the loss of hallmark features of stem cells. One such example is electromagnetic field (EMF) exposure, which is an alternative approach with promising potential. In this review, we present a critical discourse on the efficiency, practicability, and limitations of some of the relevant methods, with insurmountable evidence backing the implementation of EMF as a feasible strategy for the clinically relevant expansion of MSCs.
文献关键词:
作者姓名:
Haslinda Abdul HAMID;Vahid Hosseinpour SARMADI;Vivek PRASAD;Rajesh RAMASAMY;Azizi MISKON
作者机构:
Bio-artificial Organ and Regenerative Medicine Unit,National Defense University of Malaysia,Kuala Lumpur 57000,Malaysia;Cellular and Molecular Research Centre,Iran University of Medical Sciences,Tehran 1449614535,Iran;Institutes of Regenerative Medicine,Iran University of Medical Sciences,Tehran 1996714353,Iran;Stem Cell and Immunity Research Group,Immunology Laboratory,Department of Pathology,Faculty of Medicine and Health Sciences,Universiti Putra Malaysia(UPM),Selangor 43400,Malaysia
引用格式:
[1]Haslinda Abdul HAMID;Vahid Hosseinpour SARMADI;Vivek PRASAD;Rajesh RAMASAMY;Azizi MISKON-.Electromagnetic field exposure as a plausible approach to enhance the proliferation and differentiation of mesenchymal stem cells in clinically relevant scenarios)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(01):42-57
A类:
B类:
Electromagnetic,exposure,plausible,approach,enhance,proliferation,differentiation,mesenchymal,stem,cells,clinically,relevant,scenarios,Mesenchymal,stromal,therapy,has,been,regarded,one,most,revolutionary,breakthroughs,history,modern,medicine,owing,its,myriad,immunoregulatory,regenerative,properties,With,rapid,progress,fields,osteo,musculoskeletal,therapies,demand,treatment,modalities,becoming,increasingly,prominent,In,this,endeavor,researchers,around,world,have,devised,new,innovative,techniques,support,MSCs,while,minimizing,loss,hallmark,features,One,such,example,electromagnetic,EMF,which,alternative,promising,potential,review,we,present,critical,discourse,efficiency,practicability,limitations,some,methods,insurmountable,evidence,backing,implementation,feasible,strategy,expansion
AB值:
0.700287
相似文献
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu;Dongqing Zuo;Jie Chen;Zhigang Liu;Zhuo Wang;Liu Yang;Qihui Shi;Yingqi Hua-Shanghai Bone Tumor Institute and Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Center for Systems Biomedicine,Shanghai Jiao Tong University,Shanghai 200240,China;Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST),Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System,Minhang Hospital,Fudan University,Shanghai 201199,China;Shanghai Engineering Research Center of Biomedical Analysis Reagents,Shanghai 201203,China
Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice
Xi Gu;Xinde Hu;Daqi Wang;Zhijiao Xu;Fang Wang;Di Li;Geng-lin Li;Hui Yang;Huawei Li;Erwei Zuo;Yilai Shu-ENT institute and Department of Otorhinolaryngology,Eye & ENT Hospital,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Fudan University,Shanghai,China;Institutes of Biomedical Sciences,Fudan University,Shanghai,China;Department of Otolaryngology,the First Affiliated Hospital of Fujian Medical University,Fuzhou,China;NHC Key Laboratory of Hearing Medicine(Fudan University),Shanghai,China;Institute of Neuroscience,State Key Laboratory of Neuroscience,Key Laboratory of Primate Neurobiology,CAS Center for Excellence in Brain Science and Intelligence Technology,Shanghai Research Center for Brain Science and Brain-Inspired Intelligence,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China;State Key Lab for Conservation and Utilization of Subtropical Agric-Biological Resources,Guangxi University,Nanning,China;Shenzhen Branch,Guangdong Laboratory for Lingnan Modern Agriculture,Genome Analysis Laboratory of the Ministry of Agriculture,Agricultural Genomics Institute at Shenzhen,Chinese Academy of Agricultural Sciences,Shenzhen,China;The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science,Fudan University,Shanghai,China
Preclinical studies of the triazol0[1,5-a]pyrimidine derivative WS-716 as a highly potent,specific and orally active P-glycoprotein(P-gp)inhibitor
Sai-Qi Wang;Qiu-Xu Teng;Shuai Wang;Zi-Ning Lei;Hui-Hui Hu;Hui-Fang Lv;Bei-Bei Chen;Jian-Zheng Wang;Xiao-Jing Shi;Wei-Feng Xu;Hong-Min Liu;Xiao-Bing Chen;Zhe-Sheng Chen;Bin Yu-Department of Oncology,the Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Henan Cancer Institute,Zhengzhou 450008,China;State Key Laboratory of Esophageal Cancer Prevention&Treatment,Zhengzhou University,Zhengzhou 450052,China;College of Pharmacy and Health Sciences,St.John,s University,Queens,NY 11439,USA;School of Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450001,China;Laboratory Animal Center,Academy of Medical Science,Zhengzhou University,Zhengzhou 450052,China
Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
Jin-ping Pang;Chao Shen;Wen-fang Zhou;Yun-xia Wang;Lu-hu Shan;Xin Chai;Ying Shao;Xue-ping Hu;Feng Zhu;Dan-yan Zhu;Li Xiao;Lei Xu;Xiao-hong Xu;Dan Li;Ting-jun Hou-Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences,Cancer Hospital of University of Chinese Academy of Sciences,Zhejiang Cancer Hospital,Hangzhou 310022,China;School of Life Science,Huzhou University,Huzhou 313000,China;Institute of Bioinformatics and Medical Engineering,School of Electrical and Information Engineering,Jiangsu University of Technology,Changzhou 213001,China;State Key Lab of CAD&CG,Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。